Risk versus return:
- minimum risk given success of previous trials and this trial being more of a formality attracting partners
- potential return as 8c share becomes 50c share or more
DYOR
Ann: Last patient completes treatment in VLU Ph 2 Clinical Trial, page-15
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
